<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00231504</url>
  </required_header>
  <id_info>
    <org_study_id>P041013</org_study_id>
    <secondary_id>CRC04140</secondary_id>
    <nct_id>NCT00231504</nct_id>
  </id_info>
  <brief_title>Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count</brief_title>
  <official_title>Study of Follicle Stimulating Hormone (FSH) Receptor in Women With Low Antral Follicle Count</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The deficit in the total number of antral follicles is associated with a reduction of the&#xD;
      ovarian fertility potential in young women.&#xD;
&#xD;
      The principal objective of this study is to evaluate the relationship between FSH receptor&#xD;
      polymorphism and antral follicle count.&#xD;
&#xD;
      The investigators have designed a study of FSH receptor polymorphisms P1 and P2 as an&#xD;
      association with a low antral follicle count in the ovary.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The present study will compare the prevalence of FSH receptor polymorphisms P1 and P2 in&#xD;
      women having reduced follicle count (1 to 9 antral follicles) or normal follicle count (13 to&#xD;
      20 antral follicles) determined by ultrasound scans.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">May 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">82</enrollment>
  <condition>Antral Follicle Deficit</condition>
  <condition>Fertility</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Blood samples</intervention_name>
    <description>Blood samples</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        YOUNG WOMAN&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 to 35 years old&#xD;
&#xD;
          -  1 to 9 or 13 to 20 antral follicles&#xD;
&#xD;
          -  Caucasian, occidental Europe&#xD;
&#xD;
          -  Presence of both ovaries&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Ovarian anomalies&#xD;
&#xD;
          -  Menopause&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Other diseases&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Renato FANCHIN, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Antoine Beclere Hospital, Obstetrics and Gynaecology and Reproduction Medicine Service</name>
      <address>
        <city>Paris</city>
        <zip>92140</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2007</verification_date>
  <study_first_submitted>October 3, 2005</study_first_submitted>
  <study_first_submitted_qc>October 3, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 4, 2005</study_first_posted>
  <last_update_submitted>January 5, 2010</last_update_submitted>
  <last_update_submitted_qc>January 5, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2010</last_update_posted>
  <responsible_party>
    <name_title>Christophe Aucan</name_title>
    <organization>Department Clinical Rechearch of Developpement</organization>
  </responsible_party>
  <keyword>Polymorphism P1</keyword>
  <keyword>Polymorphism P2</keyword>
  <keyword>FSH Receptor</keyword>
  <keyword>Antral follicle count</keyword>
  <keyword>FSH receptor polymorphism</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

